Histopathologic assessment of pancreatic cancer: Does one size fit all?
Article first published online: 18 JUN 2012
Copyright © 2012 Wiley Periodicals, Inc.
Journal of Surgical Oncology
Special Issue: Seminars in Surgical Oncology: Pancreatic Cancer
Volume 107, Issue 1, pages 67–77, 1 January 2013
How to Cite
Reid, M. D., Bagci, P. and Adsay, N. V. (2013), Histopathologic assessment of pancreatic cancer: Does one size fit all?. J. Surg. Oncol., 107: 67–77. doi: 10.1002/jso.23194
- Issue published online: 13 DEC 2012
- Article first published online: 18 JUN 2012
- Manuscript Accepted: 21 MAY 2012
- Manuscript Received: 11 MAY 2012
Most solid pancreatic tumors are invasive ductal adenocarcinoma (PDAC). Because PDAC is the most common tumor, it has become synonymous with the term “Pancreas Cancer.” However, other malignant neoplasms occur in the pancreas (acinar, neuroendocrine and colloid carcinomas, and metastases) all with different outcomes. Because these tumors are often combined with PDAC in research databases, it causes misleading variability in the analysis of pancreatic cancers. We examine the histopathology of a variety of pancreatic cancers. J. Surg. Oncol. 2013;107:67–77. © 2012 Wiley Periodicals, Inc.